4.5 (535) In stock
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
Frontiers Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study)
Crohn's disease - The Lancet
Ustekinumab in treatment of Crohn's disease: design, developmen
Treatment of Psoriasis in Pregnancy
Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid, BMC Gastroenterology
JCM, Free Full-Text
Pregnancy Exposure Registries Pharma Industry and MotherToBaby
IBD in Pregnancy: Ustekinumab, Vedolizumab Use Appears Safe
Entyvio: Side Effects, Dosage, Cost, and More
Ustekinumab